The only active clinical trial for BMS drug is scheduled for completion in 2015. The other two trials were closed out a few years ago.
Clinical Trial NCT Number Sponsor Condition Start Date Phase NCT03496662 Washington University School of Medicine|Bristol-Myers Squibb|Barnes-Jewish Hospital|National Institutes of Health (NIH)|National Cancer Institute (NCI) Pancreatic Ductal Adenocarcinoma August 31, 2018 Phase 1|Phase 2 NCT01049165 Bristol-Myers Squibb Accelerated Intimal Hyperplasia February 2010 Phase 1 NCT01752985 Bristol-Myers Squibb Diabetic Kidney Disease March 18, 2013 Phase 2